PEPG - PepGen Inc. Operating profit before depreciation charges
Peptide synthesis capacities are fully prepared for clinical trials, and assets remain in ideal condition. PepGen Inc. (PEPG) revenues are based on investments and the future sale of oligonucleotide drugs for dystrophy. EBITDA reflects a trend where the 0.00 level captures fresh values. RNA delivery patents ensure a long-term monopoly and stable demand.
PepGen (PEPG) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization statistics:
- company book value details:
- business debt structure and liquidity details:
- earnings and market multiples details:
PEPG - Company Net Income|Forward Earnings PepGen Inc.|PEPG - P/E Multiple|Projected Price to Earnings Ratio PepGen Inc|PEPG - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio PepGen|PEPG - Operating profit EBITDA|Net earnings per share for the trailing year PepGen|PEPG - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months pepgen.com|PEPG - Earnings growth in current year|Expected net earnings per share growth next year PepGen Inc.
Analysis of all company metrics:PepGen Inc. - PEPG
Analyzing real cash flow from operating activities is critical for balancing operational risks and return on capital. Through a diversified network of hubs, PepGen Inc. (PEPG) minimizes disruptions in the supply of neurological drugs, which is reflected in the operating earnings trend as a metric of the business's ability to generate net profit before taxes and amortization, confirming the company's financial stability.
Who PepGen Inc. competes with
BIIB (Biogen Idec) - Profit before deduction of interest, taxes, depreciation and amortization|Neurocrine Biosciences - Operating profit EBITDA|Operating profit before depreciation charges regencellbioscience.com (RGC)|AXSM: Operating profit EBITDA|Profit before interest, taxes and amortization ACADIA Pharma (ACAD)|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Operating profit before amortization VKTX (Viking Therapeutics Corp)|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA DNLI (Denali Therapeutics Inc.)|Operating income before deduction of amortization Harmony Biosciences Inc (HRMY)|BHVN - Profit before payment of interest, taxes and amortization|AMLX (Amylyx Corp) - Operating profit before amortization|TRVI: Operating profit EBITDA|Operating profit before deduction of amortization praxismedicines.com|Operating profit before deduction of amortization AVXL|CeriBell Inc (CBLL) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA ANNX (Annexon, Inc.)|Omeros Corp (OMER) - Profit before interest, taxes and amortization|NGNE - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ACIU|VYGR: Operating profit EBITDA|Operating profit before depreciation charges Neumora Corp NMRA|Profit before payment of interest, taxes and amortization Scilex Holding Company|Operating profit before amortization TVGN (tevogen.com)|Operating profit EBITDA ACOG|CGTX - Profit before interest, taxes and amortization|Inhibikase - Operating profit before deduction of amortization|Operating profit EBITDA Cassava Pharma SAVA|ASRT - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization COYA (Coya Therapeutics, Inc.)|vistagen.com (VTGN) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Ovid Therapeutics (OVID)|Profit before payment of interest, taxes and amortization Acumen Pharma|CervoMed Corporation - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA ATHE|CLNN - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|RLMD (Relmada Therapeutics Inc) - Profit before deduction of interest, taxes, depreciation and amortization|Annovis Bio Corp - Operating profit EBITDA|Operating profit before depreciation charges Grace Therapeutics, Inc. (GRCE)|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Operating profit before amortization RVPH (Reviva Pharmaceuticals Holdings Inc.)|Operating profit before deduction of amortization MTVA (MetaVia Inc)|NRXS (NeurAxis Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Operating income before deduction of amortization Passage Bio Inc. (PASG)|NEUP - Profit before payment of interest, taxes and amortization|NERV (Minerva Neurosciences Inc) - Operating profit before amortization|ATHA: Operating profit EBITDA|Operating profit before deduction of amortization Addex|Operating profit before deduction of amortization ALZN|Cyclerion (CYCN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CRGT (Cortigent)|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|BCLI - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization CARA|CHRO: Operating profit EBITDA|Operating profit before depreciation charges Eliem Therapeutics Inc. ELYM|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Operating profit before amortization LBPH (Longboard)|Operating profit EBITDA MRNS|NKGN - Profit before interest, taxes and amortization|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Sage Therapeutics Inc. SAGE|SNPX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization anewmeds.com (WENA)|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
